Clinical Outcomes of Patients with a Light Adjustable Lens (LAL) in At Least One Eye

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
IOL
Interventions
DEVICE

Light Adjustable Lens

The Light Adjustable Lens (LAL) is a posterior chamber, UV absorbing, three-piece, foldable, photoreactive silicone intraocular lens with a squared posterior optic edge intended to be implanted in the capsular bag following phacoemulsification. Selective exposure of the implanted RxSight LAL using the Light Delivery Device (LDD) to deliver a spatially profiled UV light produces modifications in the lens curvature resulting in a spherical or spherocylindrical power change post-operatively. A subsequent lock-in exposure is delivered to the implanted LAL to stabilize the lens power.

Trial Locations (1)

18702

Bucci Laser Vision Institute, Wilkes-Barre

All Listed Sponsors
lead

Bucci Laser Vision Institute

OTHER